MX9206790A - Proceso y composicion para el desarrollo de una forma de dosis de liberacion controlada de gemfibrozil - Google Patents

Proceso y composicion para el desarrollo de una forma de dosis de liberacion controlada de gemfibrozil

Info

Publication number: MX9206790A
Authority: MX; Mexico
Prior art keywords: gemfibrozil; development; composition; controlled release; dose form
Prior art date: 1991-11-26

Application number

MX9206790A

Other languages

English (en)

Inventor

Isaac Ghebre-Sellassie

Uma Iyer

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-11-26

Filing date

1992-11-25

Publication date

1993-05-01

1992-11-25 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1993-05-01 Publication of MX9206790A publication Critical patent/MX9206790A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)

MX9206790A 1991-11-26 1992-11-25 Proceso y composicion para el desarrollo de una forma de dosis de liberacion controlada de gemfibrozil MX9206790A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US79837591A	1991-11-26	1991-11-26

Publications (1)

Publication Number	Publication Date
MX9206790A true MX9206790A (es)	1993-05-01

Family

ID=25173228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9206790A MX9206790A (es)	1991-11-26	1992-11-25	Proceso y composicion para el desarrollo de una forma de dosis de liberacion controlada de gemfibrozil

Country Status (5)

Country	Link
EP (1)	EP0614358A1 (es)
JP (1)	JPH07503236A (es)
CA (1)	CA2123677A1 (es)
MX (1)	MX9206790A (es)
WO (1)	WO1993010775A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100343062B1 (ko) *	1996-11-15	2002-07-02	에가시라 구니오	정제 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0297866A3 (en) *	1987-07-01	1989-12-13	The Boots Company PLC	Therapeutic agents
US4927639A (en) *	1989-02-02	1990-05-22	Warner-Lambert Company	Modified release gemfibrozil composition
US4925676A (en) *	1989-02-02	1990-05-15	Warner-Lambert Company	Extended release gemfibrozil composition
US4973470A (en) *	1989-06-26	1990-11-27	Warner-Lambert Company	Sustained release pharmaceutical compositions

1992
- 1992-10-15 EP EP92921783A patent/EP0614358A1/en not_active Withdrawn
- 1992-10-15 WO PCT/US1992/008782 patent/WO1993010775A1/en not_active Ceased
- 1992-10-15 CA CA002123677A patent/CA2123677A1/en not_active Abandoned
- 1992-10-15 JP JP5510096A patent/JPH07503236A/ja active Pending
- 1992-11-25 MX MX9206790A patent/MX9206790A/es not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2123677A1 (en)	1993-06-10
WO1993010775A1 (en)	1993-06-10
JPH07503236A (ja)	1995-04-06
EP0614358A1 (en)	1994-09-14

Similar Documents

Publication	Publication Date	Title
NO941719L (no)	1994-11-11	Farmasöytisk preparat med regulert frigjöringsvirkning
FI940787L (fi)	1994-02-18	Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
NO20053106L (no)	1995-04-10	Oral, analgesisk doseringsform med forlenget frigivelse.
AR230186A1 (es)	1984-03-01	Metodo para el tratamiento de una composicion que incluye el factor viii
NO983923L (no)	1991-01-08	FremgangsmÕte for fremstilling av et farmas°ytisk preparat med forlenget frigivelse
MX9204268A (es)	1994-03-31	Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AT400295B (de)	1995-11-27	Orale feste pharmazeutische dosierungsform mit programmierter wirkstofffreisetzung und verfahren zu ihrer herstellung
MX161165A (es)	1990-08-09	Procedimiento para preparar una composicion farmaceutica de liberacion prolongada
IT8820145A0 (it)	1988-04-08	Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
AR008176A1 (es)	1999-12-09	Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos
MX9204154A (es)	1993-05-01	Procedimiento para la produccion de una composicion detergente que contiene particulas de alquilsulfato y granulos de base.
DE69233090D1 (de)	2003-07-10	Trennmittel
PT90104B (pt)	1994-06-30	Processo para a preparacao de uma forma de dosagem solida, de desintegracao rapida, contendo diclofenac
MX9206790A (es)	1993-05-01	Proceso y composicion para el desarrollo de una forma de dosis de liberacion controlada de gemfibrozil
ES538606A0 (es)	1986-02-01	Un procedimiento para preparar una sustancia antibiotica seleccionada del antibiotico l 17054 y sus sales por adicion de acidos farmaceuticamente acepatables
MX9200874A (es)	1992-09-01	Compuestos de una composicion especifica, un procedimiento para su produccion y su uso.
MX9203735A (es)	1992-09-01	Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
FI925717A7 (fi)	1993-06-20	Menetelmä TiO2-pitoisten pellettien valmistamiseksi ja niiden käyttö
IT9020943A0 (it)	1990-07-13	Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
ITBS910119A0 (it)	1991-11-08	Procedimento di preparazione di una composizione farmaceutica sottoforma di microparticelle
MX9203558A (es)	1992-07-01	Forma de dosis para administrar nicardipina antagonista de calcio.
DOP1991004958A (es)	1999-02-06	Un procedimiento para preparar una composicion que comprende cefuroximo-axetil en forma de particulas
NO179817C (no)	1996-12-27	Anvendelse av 4,9,11-trien-steroider for fremstilling av et farmasöytisk preparat
AR240016A1 (es)	1990-01-31	Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
AR223682A1 (es)	1981-09-15	Procedimiento para destruir el 2-cetogluconato en una mezcla que contiene 2-cetogulonato y el citado 2-cetogluconato

Legal Events

Date	Code	Title	Description
1996-03-29	FG	Grant or registration
2014-08-29	MM	Annulment or lapse due to non-payment of fees